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Aortic Stenosis and Severe Mitral Regurgitation in
the Fetus Resulting in Giant Left Atrium and Hydrops
Pathophysiology, Outcomes, and Preliminary
Experience With Pre-Natal Cardiac Intervention
Melanie Vogel, MD,* Doff B. McElhinney, MD,* Louise E. Wilkins-Haug, MD, PHD,†
Audrey C. Marshall, MD,* Carol B. Benson, MD,‡ Amy L. Juraszek, MD,* Virginia Silva, MSN,†
James E. Lock, MD,* Gerald R. Marx, MD,* Wayne Tworetzky, MD*
Boston, Massachusetts
Objectives The objective of this article is to review anatomic, physiologic, and clinical features of fetuses and neonates with
severe mitral regurgitation (MR) in conjunction with aortic stenosis (AS) and left ventricular (LV) and left atrial
(LA) dilation and to present preliminary results of pre-natal intervention for this condition.
Background Severe fetal valvar AS with an abnormal mitral valve (MV) and MR can lead to left heart dilation, with conse-
quent compression of the right ventricle (RV); hydrops and low cardiac output are often associated.
Methods This is a retrospective review of fetuses diagnosed with AS, severe MR, and LA dilation (2002 to 2009) and neo-
nates with the same combination of abnormalities (1988 to 2009).
Results Fourteen fetuses and 7 neonates were investigated. Eleven fetuses had severe hydrops; all had polyhydramnios
and a structurally abnormal MV, abnormal MV inflow pattern, restrictive/intact atrial septum, retrograde flow in
the transverse aortic arch, and compression of the right heart. The mean indexed RV output was 326  160
ml/kg/min, lower than the normal average fetal combined ventricular output of 550  150 ml/kg/min. Ten
fetuses underwent pre-natal cardiac intervention: aortic valvuloplasty (n  8) and/or atrial septal dilation/stent-
ing (n  5). Seven of these, and 11 overall, were live born. Nine patients died (median age 6 days), and 2 pa-
tients are currently alive. All 7 patients diagnosed in the neonatal period died (median age 1 day).
Conclusions Aortic stenosis associated with significant MR in the fetus can cause severe LA and LV enlargement, leading to
low cardiac output and hydrops. Despite the potential advantages of early pre-natal diagnosis and both fetal and
neonatal interventions, this rare complex of anomalies carries a poor prognosis. (J Am Coll Cardiol 2011;57:
348–55) © 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.08.636o
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alinically significant mitral regurgitation (MR) in fetal life
s rare. It may occur in isolation or in conjunction with other
tructural and functional abnormalities, such as aortic ste-
osis (AS) with global left ventricular (LV) dysfunction and
ilation (1–4). Mitral regurgitation can also occur in con-
itions with high fetal cardiac output, such as anemia or
xtracardiac arteriovenous malformations, or with arrhyth-
ias (5–8). Mild to moderate MR is most commonly
rom the *Department of Cardiology and The Advanced Fetal Care Center,
hildren’s Hospital Boston, and Department of Pediatrics, Harvard Medical School,
oston, Massachusetts; †Department of Obstetrics & Gynecology, Brigham &
omen’s Hospital and Harvard Medical School, Boston Massachusetts; and the
Department of Radiology, Brigham & Women’s Hospital and Harvard Medical
chool, Boston Massachusetts. This study was supported by contributions from the
enrose Kitchen Table Foundation, Gig Harbor, Washington. Thomas P. Graham,
r., MD, served as Guest Editor for this paper.d
Manuscript received February 22, 2010; revised manuscript received August 18,
010, accepted August 26, 2010.bserved in evolving or established hypoplastic left heart
yndrome (HLHS) (1–4). In rare instances, AS with an
bnormal mitral valve (MV) and MR can lead to left atrial
LA) dilation with consequent MV annular dilation, with
urther exacerbation of MR. The aim of this study was to
eview the anatomic, physiologic, and clinical features of
etuses and neonates with the rare but distinct combination
f severe MR, AS, and severe LA enlargement who were
anaged at Children’s Hospital Boston and to report our
reliminary experience with pre-natal intervention for this
ondition.
ethods
atients. We included all fetuses with valvar AS, severe
R, and severe LA dilation evaluated by echocardiography
t Children’s Hospital Boston from 2002 to 2009. This is a
ifferent cohort than the fetuses with AS and evolving
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January 18, 2011:348–55 Fetal Intervention for Severe MR With HydropsLHS or with established HLHS and an intact or restric-
ive atrial septum, which have been the subject of prior
eports from our group (1–4). We also evaluated patients
hat did not undergo fetal echocardiography but were
iagnosed in the first week of life with the same combina-
ion of abnormalities from 1988 to 2009. The study was
erformed in conjunction with a protocol that was approved by
he Children’s Hospital Committee for Clinical Investigations.
ardiovascular and noncardiovascular ultrasound. All
etal patients underwent at least 1 detailed obstetric
onogram and echocardiogram, during which a full ana-
omic and Doppler survey was performed. Evaluations
ncluded fetal biometry, anatomic measurement of left
nd right heart structures, and cardiac and extracardiac
oppler measurements.
Fetal biometry consisted of measurement of the biparietal
iameter, head circumference, femur length, and abdominal
ircumference. In fetuses with ascites, the abdominal cir-
umference measurement was taken in the standard fashion,
ecognizing that this would likely lead to an overestimate of
etal weight. Fetal weight was estimated using the method
f Hadlock et al. (9). Gestational age–based z-scores were
alculated for fetal weight from equations reported by
oubilet et al. (10) and for head circumference, biparietal
iameter, femur length, and abdominal circumference from
quations reported by Hadlock et al. (11). Because measure-
ent of abdominal circumference was confounded by the
resence of ascites and weight calculated by the Hadlock
ethod was above the 50th percentile for gestational age in
lmost all cases, the mean (50th percentile) weight for
estational age was used to index right ventricular (RV)
utput to avoid underestimation of output. Other factors
ecorded on noncardiovascular ultrasound included the
resence of polyhydramnios, fetal hydrops, skin edema,
scites, pericardial or pleural effusion, and fetal sex (10).
Anatomic assessment included measurement of the fol-
owing left and right heart structures: LA dimensions, MV
nnulus in diastole, LV length (diastole and systole), LV
olume (using the 5/6 area  length method), aortic valve
nd ascending aorta diameters, tricuspid valve (TV) and
ulmonary valve annulus diameter, and RV end-diastolic
ength. The MV was described as anatomically normal or
bnormal, and the presence of accessory chordal attach-
ents and echogenic papillary muscles was recorded. The
V was further characterized as normal or dilated, and the
resence or absence of endocardial fibroelastosis was noted.
he pulmonary veins were categorized as normal, dilated, or
ompressed, and the patency and size of the foramen ovale
as recorded. All reported z-scores are based on gestational
ge and were calculated from unpublished normative data
ollected at Children’s Hospital Boston between 2005 and
007 on 232 normal fetuses.
Cardiac Doppler evaluation included measurement of
V and TV inflow patterns and durations, MV and TV
egurgitant jet color Doppler vena contracta width, LV
ressure (maximum instantaneous MR jet velocity), and Caximum instantaneous AS gra-
ient and color Doppler jet
idth. The direction of patent
oramen ovale flow was de-
cribed. The RV output was cal-
ulated as: the product of pulmo-
ary valve velocity-time integral
m)  heart rate (beats/min) 
alve area (cm2).
Extracardiac Doppler measure-
ents included velocities and flow
atterns in the middle cerebral ar-
ery, umbilical artery, umbilical
ein, and ductus venosus.
ata analysis. Because of the
mall number of fetuses and ne-
nates, data are presented primarily in descriptive fashion.
natomic and physiologic variables for which internally
erived z-scores were available were compared with normal
z  0) using 1-sample t test. The RV output indexed to
alculated weight and to the 50th percentile weight for
estational age (assuming that hydrops would confound
stimation of weight) was compared with published normal
alues of fetal combined ventricular output (429  100
l/kg/min to 550  150 ml/kg/min) (12–15) and with
reviously published cardiac output data for fetuses with
LHS (16) using 1-sample t test. Indexed RV output was
lso compared with unpublished pre-intervention data in 75
etuses that underwent pre-natal aortic valvuloplasty for AS
ith evolving HLHS at our center, using the Wilcoxon
ank sum test. In all cases, LV output was negligible;
herefore, the RV was assumed to provide essentially all
ardiac output. No other statistical analysis was performed.
ata are presented as frequency (%), median (range), or
ean SD. For 1-sample t test analysis, only p 0.01 was
onsidered significant.
esults
atients. Fourteen fetuses with severe MR, AS, and severe
A and LV dilation underwent echocardiography at a
edian gestational age of 28.6 weeks (range 21.6 to 33.3
eeks) (Table 1). Four of these 14 patients were from the
sual referral base of Children’s Hospital, and 10 were
eferred from elsewhere. Eight of these fetuses were in-
luded in a prior report dealing with fetal cardiac instability
uring pre-natal intervention, but none of the data included
n this report were presented in the prior report (17). One
atient was known to have an abnormal karyotype (mosaic
urners [XY, XO]). Two patients had a significant family
istory: 1 had a sibling with trisomy 18 and another had a
ibling that underwent heart transplant for dilated cardio-
yopathy. Thirteen fetuses were male and 1 was female.
In addition to the above fetuses, 7 neonates with a
edian age of 1.0 day (1.0 to 8.0 days) presented to
Abbreviations
and Acronyms
AS  aortic stenosis
HLHS  hypoplastic left
heart syndrome
LA  left atrial/atrium
LV  left ventricular/
ventricle
MR  mitral regurgitation
MV  mitral valve
RA  right atrial/atrium
RV  right ventricular/
ventricle
TV  tricuspid valvehildren’s Hospital between 1988 and 2000 with an en-
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Fetal Intervention for Severe MR With Hydrops January 18, 2011:348–55arged LA, severe MR, and AS. Five were male and 2
emale.
natomic and physiologic findings. NONCARDIOVASCULAR
ETAL ULTRASOUND. Median z-scores for fetal biometric
easurements were 1.39 (0.13 to 3.58) for weight, 1.80
1.77 to 3.28) for biparietal diameter, 0.55 (2.79 to
.70) for femur length, 1.45 (0.82 to 7.79) for abdominal
ircumference, and 0.04 (1.71 to 1.64) for head
ircumference.
Eleven of 14 fetuses had severe hydrops: 9 had skin
hickening, 9 had ascites, 7 had a pericardial effusion, and 4
ad a pleural effusion. Polyhydramnios, ranging from mild
o severe, was present in all 14 cases. Two of the 3 fetuses
ithout hydrops at the time of diagnosis were the youngest
n the cohort (21.6 and 23.3 weeks’ gestation).
ARDIOVASCULAR ULTRASOUND. All fetuses had severe
R with AS and marked LA and LV dilation (Fig. 1). The
ost notable anatomic and physiologic features included a
tructurally abnormal MV (Figs. 1D and 2), abnormal MV
Fig. 3) and TV inflow patterns, dilated central veins, a
estrictive or intact atrial septum that was bulging left to
ight, and retrograde flow in the transverse aortic arch.
natomic and Doppler findings are summarized in Table 2.
EFT HEART ANATOMY AND PHYSIOLOGY. The pulmonary
eins were compressed in all but 2 fetuses, in which they
etails of Fetuses Diagnosed With AS, Severe MR, and Severe LATable 1 Details of Fetuses Diagnosed With AS, Severe MR, an
Fetus #
GA at
Presentation
(Weeks) Fetal Cardiac Interventions
Fetal Arrhythm
(Treatment
1 29.3 Atrial balloon dilation
2 33.3 None PJRT (flecanid
digoxin)
3 26.2 Aortic valvuloplasty
4 32.7 Aortic valvuloplasty
5 29.9 Atrial balloon dilation
6 28.8 Aortic valvuloplasty
7 23.3 Aortic valvuloplasty
8 23.4 Aortic valvuloplasty and
atrial balloon dilation
Re-entrant SVT
(digoxin)
9 31.7 Aortic valvuloplasty
10 30.1 Aortic valvuloplasty, atrial balloon
dilation, atrial septal stent
placement
11 27.6 None
12 21.6 None
13 28.4 None
14 25.1 Aortic valvuloplasty and
atrial balloon dilation
Fetal demise 1 day after fetal cardiac intervention.
AS  aortic stenosis; ASD  atrial septal defect; GA  gestational age; LA  left atrial; MR 
eciprocating tachycardia; SVT  supraventricular tachycardia; TOP  termination of pregnancy.ere dilated. As a result, pulmonary venous Doppler data aere only available in 4 fetuses; 1 of these was normal, and
were abnormal, with evidence of ventricular systolic
eversal. All fetuses had severe LA dilation (Fig. 1, Table 2).
n average, the LA to right atrial (RA) lateral dimension
atio was approximately 3:1. The atrial septum was bulging
eft to right in all patients, and there was no detectable right
o left or left to right flow across the foramen ovale in 7. The
V was dilated and empirically larger than the RV in the
ateral dimension in all fetuses (Table 2). The LV systolic
unction and generated pressure varied (Table 2). Left
entricular endocardial fibroelastosis was present in 13
etuses (Fig. 1C). The MV was anatomically abnormal in all
etuses, with echogenic papillary muscles and a bright,
mmobile anterior leaflet (Fig. 1D). The MV papillary
uscles were attached more basally than normal, with
hortened immobile chordae and the appearance of a mitral
rcade (18) (Fig. 2). The MV annulus was dilated (z-score
2) in 9 fetuses. The MR was severe in all fetuses, with a
edian MR jet Doppler vena contracta width of 3.6 mm
Fig. 1B, Table 2). All fetuses had an abnormal MV
oppler inflow pattern, and the inflow time was abnormally
hort in 1 (Fig. 3, Table 1). In all 11 fetuses with partial
-A wave fusion on the MV inflow signal, there was a
ominant E wave. All fetuses had demonstrable flow across
he aortic valve, with a median maximum instantaneous AS
radient of 17 mm Hg. Four fetuses had antegrade flow,
onere LA Dilation
GA at Birth
(Weeks) Post-Natal Intervention Status
31.4 Balloon aortic valvuloplasty Alive, 45 months
34.4 None Death at 1 day
Fetal demise None Fetal death at 26.7 weeks*
37.3 MV repair, ASD closure,
PDA ligation
Death at 38 days
34.3 None Death at 1 day
35.4 Norwood stage I,
MV closure
Death at 86 days
29.3 Atrial balloon dilation with
stent placement
Death at 1 day
37.6 Neonatal Ross,
MV replacement, transplant
Death at 94 days
31.9 Atrial balloon dilation,
deterioration during
procedure leading
to death
Death at 1 day
37.3 Balloon aortic valvuloplasty,
neonatal Ross, MV repair
Alive, 6 months
TOP None TOP
Unknown None Death at 1 day
29.4 Atrial balloon dilation Death at 1 day
Fetal demise None Fetal death at 25.4 weeks*
egurgitation; MV  mitral valve; PDA  patent ductus arteriosus; PJRT  paroxysmal junctionalDilatid Sev
ia
)
e,nd 10 had retrograde flow in the ascending aorta; all had
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January 18, 2011:348–55 Fetal Intervention for Severe MR With Hydropsetrograde flow in the transverse aortic arch and right to left
ow across the ductus arteriosus. One fetus had mild aortic
egurgitation.
IGHT HEART ANATOMY AND PHYSIOLOGY. In all fetuses,
he RA and RV appeared distorted and compressed by the
ilated LA and LV (Figs. 1A and 1B). The TV annulus
iameter was within the normal range in 12 fetuses and just
bove normal in 2 (Table 2). The TV inflow Doppler was
bnormal in 13 fetuses: partially fused in 7 and monophasic
fused) in 6. Among the 7 patients with partially fused TV
nflow signal, the E-wave was dominant (with an E/A ratio
2) in 4, and the A-wave was dominant in 3 (E/A ratio
.58 to 0.78). The TV inflow time was lower than normal,
ith a median z-score of 1.9 (3.1 to 0.4). Four fetuses
ad moderate (n  3) or severe (n  1) TV regurgitation.
The average RV output indexed to estimated fetal weight
as 309 96 ml/kg/min (148 to 555 ml/kg/min). If all fetuses
Figure 1 Fetal Echocardiogram Images
(A) Fetal echocardiogram in a 4-chamber view, demonstrating severe left atrial (LA
tial obstruction of the tricuspid valve. The right ventricle (RV) is compressed by a d
same fetus demonstrating severe LA and LV enlargement, severe mitral regurgitat
(arrow). There is significant compression of the RA and RV. (C and D) These obliq
ascites (A), and moderate to severe LV endocardial fibroelastosis (arrows). In D, tere assumed to be at the 50th percentile of weight for mestational age, the indexed RV output was 326  160
l/kg/min (127 to 617 ml/kg/min). Both of these values are
ignificantly lower than published normal values for combined
entricular output, which range from 429 100 to 550 150
l/kg/min (both p  0.001), and than the cardiac output of
82  77 ml/kg/min reported by Szwast et al. (16) for fetuses
ith HLHS (p  0.014 for calculated weight) (12–16). They
ere also significantly lower than pre-intervention RV output
n 75 fetuses with AS that underwent pre-natal aortic valvu-
oplasty for evolving HLHS at our center (436  142 ml/kg/
in; p  0.002 for calculated weight).
In 11 patients, Doppler flow patterns in the umbilical
rtery, umbilical vein, ductus venosus, and/or middle
erebral artery were abnormal. One patient had reversed
nd-diastolic flow in the umbilical artery, 6 had notching
f the umbilical vein, 5 had flow reversal in the ductus
enosus (2 not measured), and 6 had an abnormally low
rgement, with bowing of the atrial septum (*) into the right atrium (RA) and par-
left ventricle (LV). (B) Doppler color flow image in a 4-chamber view from the
d an anatomically abnormal mitral valve with an echogenic anterior leaflet
nsverse images from a different fetus demonstrate severe LA enlargement,
erior leaflet of the mitral valve (arrow) is bright and immobile.) enla
ilated
ion, an
ue tra
he antiddle cerebral artery pulsatility index (3 not measured)
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Fetal Intervention for Severe MR With Hydrops January 18, 2011:348–5519 –21). Doppler data were not obtained for flow in the
nferior vena cava.
EONATES. All 7 patients diagnosed in the newborn period
ad severe MR, AS, and severe LA enlargement. The median
ortic valve and ascending aortic z-scores were 4.1 (4.4 to
.8) and 2.0 (4.3 to 2.3), respectively. All had severe LV
ysfunction, variable amounts of endocardial fibroelastosis, and
ight heart compression.
utcome. FETUSES AND FETAL INTERVENTION. Ten of 14
etuses underwent technically successful pre-natal cardiac in-
ervention (Table 1), including aortic valvuloplasty in 8 and
trial balloon dilation in 5 (1 with atrial septal stent placement).
even of these 10, and 11 overall, were live born, all before 37.8
eeks’ gestational age. The parents of 1 patient elected termi-
ation of pregnancy, and 2 had a fetal demise the day after fetal
Figure 2 Autopsy Specimens
(A) An autopsy specimen from patient 14, who died at 25.4 weeks’ gestation
after fetal intervention, demonstrates a severely abnormal mitral valve with an
arcade leaflet-tension apparatus (arrows), along with shortened chordae and
basal displacement of the papillary muscles. The LV is opened and viewed
from the apex. (B) The autopsy specimen from this patient also demonstrates
the severe LV and LV dilation, with an enlarged and lobulated left atrial
appendage (LAA). Abbreviations as in Figure 1.ntervention. Nine of the 11 live-born patients died at a medianFigure 3 Mitral and Tricuspid Valve Doppler Inflow Patterns
(A) Normal mitral valve Doppler. (B) Abnormal Doppler with a partially
fused mitral valve inflow pattern. (C) Tricuspid valve monophasic Doppler pattern.
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January 18, 2011:348–55 Fetal Intervention for Severe MR With Hydropsge of 6 days (1 to 94 days), including 4 on the first day of life.
he median weight at birth or fetal demise was 1,900 g (979
o 4,000 g). Two patients are currently alive at 3 years and 3
onths, respectively; both had a successful fetal intervention.
one of the 3 patients without hydrops at the time of diagnosis
urvived beyond the neonatal period.
EONATES. All 7 patients diagnosed in the neonatal period
ied soon after birth, at a median age of 1 day (1 to 86 days).
he median birth weight was 2,550 g (1,500 to 3,700 g). All
neonates underwent cardiac catheterization with the inten-
ion to perform a balloon aortic valvuloplasty. Five patients
nderwent balloon dilation of the aortic valve, with additional
alloon atrial septal dilation in 1 patient. Two others under-
ent initial balloon atrial septal dilation but deteriorated
uring the catheter procedure before aortic valve dilation could
chocardiographic Findings in 14 Fetusesith AS, Severe MR, and Severe LA DilationTable 2 Echo ardiographic Finding in 14 FetusesWith AS, Severe MR, and Severe LA Dilation
Pulmonary veins
Compressed 12
Dilated 2
LA size (mm)
Lateral dimension 27.7 (14.3 to 37.0)
Superior-inferior dimension 26.6 (13.0 to 31.0)
Patent foramen ovale
Large 1
Small 6
Intact atrial septum 7
MV annulus diameter z-score 2.5 (0.1 to 7.2)
MR vena contracta jet width (mm) 3.5 (2.6 to 5.2)
MV inflow pattern
Partially fused 11
Monophasic flow pattern 3
MV inflow time z-score 0.4 (2.2 to 1.6)
LV pressure (mm Hg) 36 (6 to 64)
LV end-diastolic volume z-score 4.4 (1.6 to 7.2)*
LV end-diastolic length z-score 2.0 (0.1 to 7.0)*
LV end-diastolic short axis z-score 4.7 (1.7 to 8.4)*
LV ejection fraction (%) 38.5 (7.669.1)
Aortic valve annulus diameter z-score 3.0 (4.4 to 0.8)*
Ascending aorta diameter z-score 1.4 (3.7 to 2.3)
AS gradient (mm Hg) 13 (1 to 59)
Right atrial size lateral dimension (mm) 8.6 (4.0 to 20.0)
TV annulus diameter z-score 0.1 (1.5 to 2.1)
TV inflow pattern
Normal 1
Partially fused 7
Monophasic flow pattern 6
TV inflow time (ms) 147 (120 to 205)
TV inflow time z-score (ms) 1.9 (3.2 to 0.4)*
RV end-diastolic length z-score 1.1 (3.4 to 3.6)
Pulmonary valve annulus diameter z-score 0.8 (0.9 to 3.0)
Cardiothoracic area ratio (%) 44 (32 to 60)
alues represent frequency (%) or median (range). *p  0.001 by 1-sample t test; for all other
-scores, p  0.01.
LV left ventricular; RV right ventricular; TV tricuspid valve. Other abbreviations as in Table 1.e performed. oiscussion
his article reports the findings of a cohort of fetuses and
eonates with the unique constellation of severe MR, AS,
estrictive or intact atrial septum, and severely dilated LA,
sually in association with endocardial fibroelastosis of the LV
nd MV tension apparatus. These cardiac abnormalities were
ssociated with hydrops in 11 fetuses. Fetuses with these
ndings have been described previously but only in isolated
eports (22–25). We contend that this is a unique complex of
efects that should be thought of as a distinct clinical entity,
hich may be on the severe end of the mitral arcade spectrum
18). The primary anatomic anomaly in these fetuses is most
ikely an abnormal MV resulting in MR, AS leading to
ncreased wall stress and dilation, primary endocardial fibro-
lastosis, or abnormalities of both aortic and mitral valves. The
rognosis of this complex is very poor, with survival beyond the
eonatal period in only 2 of the 21 patients. The consistent
natomic and physiologic features of these fetuses may allow
nsight into the pathophysiology of cardiac hydrops (26,27) in
his setting and provide a rationale for pre-natal cardiac
ntervention for this dire condition.
We propose that the underlying cause of hydrops in
etuses with this constellation of findings is elevated sys-
emic venous pressure, which is a consequence of right heart
ompression by the dilated LA and LV, which in turn is due
o AS and severe MR. The restrictive or intact atrial septum
ontributes further to left heart dilation and increased LA
ressure because there is no natural avenue for decompres-
ion of the left heart. The resulting volume load on the LV
eads to MV annular dilation, which further exacerbates the
R. The dilated LA and LV can result in mechanical
ompression of the RA and RV, which might impede both
he filling and emptying of the right heart. This may result
n elevated systemic venous pressures, as indicated by flow
eversal in the ductus venosus and notching on the umbilical
enous flow signal, which may lead to hydrops, ascites, and
kin edema given the fetus’s low albumin and oncotic
ressures (28). High central venous pressure also likely
esults in increased pressure in the thoracic duct, which may
mpair lymphatic drainage. In addition, both diastolic and
ystolic RV function appear to be impaired: diastolic dys-
unction is suggested by an abnormal Doppler TV inflow
ignal (either partially or completely fused) and abnormal
ow in the ductus venosus and umbilical vein, whereas
ystolic dysfunction is evidenced by low RV output, which
ay also be a function of reduced filling. Three fetuses in
his series did not have hydrops, but there were no obvious
ardiac functional differences between these fetuses and
hose with hydrops. Because 2 of the 3 fetuses without
ydrops were the youngest in the cohort, it is possible that
ydrops had simply not developed yet in the same hemo-
ynamic context as the older fetuses with hydrops.
etal intervention. Although more than half of the fetal
atients in this series underwent pre-natal intervention, the
verall survival was still poor. With this complex cardiac
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Fetal Intervention for Severe MR With Hydrops January 18, 2011:348–55nomaly, there are theoretic advantages to balloon dilation
f both the aortic valve and the atrial septum, both of which
e have reported in patients with evolving or established
LHS (those series did not include the patients in this
eport) (1–4). Given that severe MR is the most burden-
ome aberration, procedures that promote aortic antegrade
ow, such as aortic valve dilation (1), might improve
orward flow, reduce LV afterload, and therefore decrease
he absolute and relative amount of MV regurgitant flow. In
ddition to relieving LV outflow obstruction, creation or
nlargement of an interatrial communication has theoretic
enefits (2,3). If an adequately sized hole can be created, this
ill allow LA decompression, which, in conjunction with
mproved antegrade flow through the LV, may ameliorate
A hypertension and enlargement. This will consequently
elieve RA and RV compression and possibly reduce distor-
ion or compression of other thoracic structures such as the
ungs, airways, or esophagus. In addition, the left to right
trial flow might improve RV preload and consequently RV
utput. The LA decompression in utero may also have
mplications for post-natal hemodynamics, insofar as LA
nd pulmonary venous hypertension owing to MR, in
onjunction with pulmonary venous compression by the
ilated LA, may impede pulmonary blood flow in the
ewborn and contribute to impaired oxygenation, pulmo-
ary hypertension, and pulmonary edema.
Although 4 of the 5 fetuses in which we performed atrial
eptoplasty did not undergo aortic valve dilation, atrial
eptoplasty alone is unlikely to be effective in these fetuses
or the reasons discussed previously. Unfortunately, both
ortic valvuloplasty and atrial septal opening procedures
ere performed successfully in only 1 of the fetal patients.
n the others, we did not appreciate the potential impor-
ance of performing both procedures (early in our experi-
nce), had procedural adverse events preventing us from
ompleting both procedures (17), or were technically unable
o perform one or the other. Atrial septoplasty can be very
hallenging in these fetuses, given that the RA is severely
ompressed and can be difficult to enter.
ost-natal intervention. The structure and orientation of
he foramen ovale and the foramen flap valve allow blood to
ow more readily from right to left, such that blood flow in
ost right heart lesions is adequately redirected to the left
eart. In contrast, in fetuses with left-sided cardiac disease,
mpaired or absent LV filling may cause LA hypertension
nd consequent restriction or closure of the foramen ovale.
nlike HLHS, in which atrial septal restriction can lead to
ulmonary venous dilation, severe LA enlargement caused
ompression of the pulmonary veins in the majority of
etuses in this series (12 of 14). Regardless of the appearance
f the pulmonary veins, severe LA hypertension and inad-
quate LA egress in fetuses with this lesion, as in those with
LHS, may critically limit pulmonary blood flow in the
erinatal period with lethal consequences. As such, imme-
iate post-natal decompression of the LA should be antic-pated in fetuses that survive to birth. Even with acuteeonatal intervention and atrial septal opening, survival in
ur experience has been poor.
onclusions
ortic stenosis associated with significant MR in the fetus
an cause severe LA enlargement, ultimately leading to low
ardiac output and hydrops, with poor prognosis. The
natomic and physiologic findings presented in this report
upport a proposed etiology for fetal hydrops and a rationale
or pre-natal cardiac intervention. Despite the potential
dvantages of early pre-natal diagnosis and both fetal and
eonatal cardiac interventions, this rare complex of anom-
lies carries a poor prognosis. These findings will help
nform parental counseling and may prompt innovative
pproaches to therapy, including fetal cardiac intervention.
eprint requests and correspondence: Dr. Wayne Tworetzky,
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